BioCardia (BCDA) Asset Writedowns and Impairment (2010 - 2024)
BioCardia's (BCDA) quarterly Asset Writedowns and Impairment came in at -$10000.0 in Q2 2024, up 58.33% quarter-over-quarter from -$24000.0 in Q1 2024.
Powered by 
Analysis
BioCardia (BCDA) Asset Writedowns and Impairment (2010 - 2024) Analysis & Trends
BioCardia (BCDA) has reported Asset Writedowns and Impairment for 8 consecutive years, with -$10000.0 the latest figure, recorded in Q2 2024.
- On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to -$10000.0 in Q2 2024; TTM through Mar 2025 was -$10000.0, a 900.0% decrease from a year earlier, with the FY2024 full-year figure at -$34000.0, down 247.83% from the prior year.
- Asset Writedowns and Impairment was -$10000.0 for Q2 2024 at BioCardia, up from -$24000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $12000.0 in Q4 2023 and troughed at -$24000.0 in Q1 2024.
- A 3-year average of -$666.67 and a median of $3500.0 in 2020 frame the typical range for Asset Writedowns and Impairment.
- The widest YoY moves for Asset Writedowns and Impairment: up 50.0% in 2020, down 94.87% in 2020.
- Over 3 years, Asset Writedowns and Impairment stood at $4000.0 in 2020, then soared by 200.0% to $12000.0 in 2023, then tumbled by 183.33% to -$10000.0 in 2024.
- The last three Asset Writedowns and Impairment figures came in at -$10000.0 (Q2 2024), -$24000.0 (Q1 2024), and $12000.0 (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.56 Bn | 2.60 Bn | 251.50 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.19 Bn | 1.40 Bn | 251.87 Mn |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn |
| 10 | BioCardia | 13.18 Mn | 9.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -10,000.00 |
| Mar 31, 2024 | -24,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Sep 30, 2023 | 11,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Dec 31, 2019 | -53,000.00 |
| Jun 30, 2019 | 78,000.00 |
| Mar 31, 2019 | 2,000.00 |
| Dec 31, 2018 | -3,000.00 |
| Sep 30, 2018 | 13,000.00 |
| Jun 30, 2018 | 12,000.00 |
| Dec 31, 2012 | 24,000.00 |
| Dec 31, 2011 | 52,000.00 |
| Sep 30, 2011 | -9,000.00 |
| Sep 30, 2010 | 5.28 Mn |